Esperion Therapeutics
ESPR
#6750
Rank
โ‚น77.79 B
Marketcap
โ‚น301.91
Share price
0.00%
Change (1 day)
47.88%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น77.79 Billion

As of September 2026 Esperion Therapeutics has a market cap of โ‚น77.79 Billion. This makes Esperion Therapeutics the world's 6750th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น77.79 B-9.51%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น15.449 T 19,757.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น8.052 T 10,250.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น241.58 B 210.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น92.51 B 18.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น431.96 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.191 T 1,431.65%๐Ÿ‡บ๐Ÿ‡ธ USA